FCRL4 and colorectal carcinoma: Moreover, immunostaining for FCRL4 and double staining for both CD20 and FCRL4 performed on CRC samples from short-term survivors, also showed mean percentages of single or double positive cells significantly (p<0.0001) higher than that found in CRC samples from long-term survivors (Table 6 and Figures 3E–H).